Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ergocalciferol Repletion in CKD Stage 5D
NCT01312441Phase 4Terminated
- Sponsor
- Albany College of Pharmacy and Health Sciences
- Start
- Jan 2011
- Primary completion
- Jun 2015
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Vitamin D deficiency (VDD) comparing Ergocalciferol with Placebo (2 arms). Primary endpoint: Sustainability of 25-hydroxy-vitamin D levels at 12 months. Started Jan 2011; status: terminated.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT01312441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01312441.